China speeds up clinical trials for Covid-19 cure


WUHAN (China Daily/ANN): With the public eagerly anticipating effective drugs to cure the novel coronavirus pneumonia, a medical ethics committee at the forefront of fighting the outbreak in Wuhan has quickened the pace of approving clinical trials.

Several programmes related to the diagnosis and treatment of the disease have gained ethical approval from Huazhong University of Science and Technology and are being carried out by the university, including two drugs that are under clinical trials, said Chen Jianguo, vice-president of the university.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
china , clinical , trials , Wuhan , covid-19 , drugs

Next In Regional

Why China’s humanoid robots are still waiting for their ‘ChatGPT moment’
Singapore turns tide in evolving fight against scams
Africa emerges as new arena in US-China competition over artificial intelligence
China’s parents are outsourcing the homework grind to AI
Where are China’s AI doomers?
China's overstretched healthcare looks to AI boom
Smaller, faster, smarter: Chinese transistor ready for future AI chips
Jimmy Lai to be sentenced on Monday in Hong Kong national security trial
Chinese AI firms defend safety practices, push back on Western criticism
Chinese AI goes next level in geometry at a top US maths Olympiad

Others Also Read